Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biex To Educate Clinicians/Payers On SalEst Cost Benefits Prior To Roll-Out

This article was originally published in The Gray Sheet

Executive Summary

Biex' 40-member sales and clinical support organization is preparing for the launch of the SalEst salivary estriol test in the U.S. with a six-week education program aimed at physicians and payers on the utility of the product as an aid in identifying women at risk for preterm labor and delivery.

You may also be interested in...

FDA Approval To Reimbursement A Challenge For Start-Ups – Biex Founder

Biex, Inc. plans to relaunch its salivary estriol test for detecting pre-term labor (PTL) with a retooled business strategy after experiencing difficulties in its initial attempts to gain sufficient reimbursement coverage

Amunix Raises $117m To Take Novel T-Cell Engager Into The Clinic

Amunix’s XTEN technology for half-life extension and precise drug delivery has been used by multiple partners over the past 15 years, but now the firm is building its own cancer therapy pipeline.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts